NGL Fine Chem, a company in the Pharmaceuticals industry, reported revenue of ₹157 crore and net profit of ₹13 crore for the September 2026 quarter.
NGL Fine Chem (NSE: NGLFINE) closed at ₹2,747.60 on 20 Nov 2026, up 97.4% over the past year. Its market capitalisation is ₹1,698 crore and it trades at 26.6 times earnings.
Incorporated in 1981, NGL Fine-Chem Ltd is a manufacturer and exporter of pharmaceuticals and intermediates for usage in veterinary and human health.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.